Ratios in Focus: Analyzing Celestica, Inc (CLS)’s Price-to-Cash and Price-to-Free Cash Flow

Abby Carey

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

In the latest session, Celestica, Inc (NYSE: CLS) closed at $235.34 up 0.71% from its previous closing price of $233.67. In other words, the price has increased by $0.71 from its previous closing price. On the day, 2.69 million shares were traded. CLS stock price reached its highest trading level at $244.58 during the session, while it also had its lowest trading level at $233.87.

Ratios:

For a deeper understanding of Celestica, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 86.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 70.36. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.55.

On July 21, 2025, Citigroup started tracking the stock assigning a Neutral rating and target price of $172.

On February 21, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $166.JP Morgan initiated its Overweight rating on February 21, 2025, with a $166 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’25 when Wilson Michael Max sold 25,000 shares for $98.73 per share. The transaction valued at 2,468,250 led to the insider holds 1,784 shares of the business.

Agrawal Alok K. bought 3,672 shares of CLS for $438,694 on May 30 ’25. On Mar 31 ’25, another insider, Laurette Koellner, who serves as the Director of the company, bought 100,000 shares for $82.69 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 27071793152 and an Enterprise Value of 27771092992. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 51.12, and their Forward P/E ratio for the next fiscal year is 34.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.56 while its Price-to-Book (P/B) ratio in mrq is 15.40. Its current Enterprise Value per Revenue stands at 2.623 whereas that against EBITDA is 30.186.

Stock Price History:

The Beta on a monthly basis for CLS is 1.84, which has changed by 3.2243762 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $261.83, while it has fallen to a 52-week low of $52.25. The 50-Day Moving Average of the stock is 7.05%, while the 200-Day Moving Average is calculated to be 69.41%.

Shares Statistics:

For the past three months, CLS has traded an average of 3.39M shares per day and 2595180 over the past ten days. A total of 115.00M shares are outstanding, with a floating share count of 114.44M. Insiders hold about 0.51% of the company’s shares, while institutions hold 74.41% stake in the company. Shares short for CLS as of 1757894400 were 5001788 with a Short Ratio of 1.48, compared to 1755216000 on 5948533. Therefore, it implies a Short% of Shares Outstanding of 5001788 and a Short% of Float of 4.37.

Earnings Estimates

The market rating for Celestica, Inc (CLS) is a result of the insights provided by 13.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $1.5, with high estimates of $1.61 and low estimates of $1.38.

Analysts are recommending an EPS of between $5.89 and $5.45 for the fiscal current year, implying an average EPS of $5.58. EPS for the following year is $6.87, with 15.0 analysts recommending between $8.6 and $6.35.

Revenue Estimates

A total of 12 analysts believe the company’s revenue will be $3.02B this quarter.It ranges from a high estimate of $3.09B to a low estimate of $2.99B. As of. The current estimate, Celestica, Inc’s year-ago sales were $2.5BFor the next quarter, 12 analysts are estimating revenue of $3.05B. There is a high estimate of $3.15B for the next quarter, whereas the lowest estimate is $2.82B.

A total of 14 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $12.12B, while the lowest revenue estimate was $11.38B, resulting in an average revenue estimate of $11.66B. In the same quarter a year ago, actual revenue was $9.65BBased on 13 analysts’ estimates, the company’s revenue will be $13.68B in the next fiscal year. The high estimate is $14.32B and the low estimate is $13.3B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.